KAISERSLAUTERN, Germany, February 3, 2017 /PRNewswire/ -- pharmasol, a global leader in software development and product implementation for the Life Sciences industry, today announced two new Argus hosted customers.

With an increased focus on E2BR3 readiness, customers are moving towards the most recent release of Oracle Argus Safety. pharmasol is pleased to announce the addition of more customers to its client base running Argus Standard Edition 8.1.

Oracle Argus offers the following benefits:

** Make faster, better safety decisions with scientific querying and analytics

** Improve quality and efficiency through safety integration and automation

** Enhance compliance with E2B exchange and periodic reporting

** Conduct global case processing that scales easily to millions of cases

Using pharmasol's proprietary accelerated implementation approach, rapidLIVE, together with secure ISO-certified hosting from our EU data centres, pharmasol offers the most straightforward and cost effective deployment for this leading global safety database from Oracle.

rapidLIVE provides a pre-configured, ready to use workflow, with dedicated customer environments, thus enabling faster deployment into productive use and reducing overall implementation time to just two to three months.

About pharmasol

pharmasol is a leading provider of innovative applications, GxP compliant hosting and implementation services to the life sciences industry. With tools to automate complex business processes and the option to host applications in a secure managed data centre, pharmasol is trusted by leading pharmaceutical, medical device and contract research companies to optimize workflows and ensure compliance.

http://www.pharmasol.de

SOURCE pharmasol

ICH guideline E2B (R3) on electronic transmission of individual case safety reports (ICSRs) - data elements and message specification. The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) published guidelines that have designated “E” to stand for efficacy.